These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12570226)
41. Acute neuroleptic-induced akathisia in patients with traumatic paraplegia: two case reports. BrĂ¼ne M Gen Hosp Psychiatry; 1999; 21(5):386-8. PubMed ID: 10572782 [No Abstract] [Full Text] [Related]
42. Ziprasidone-induced tardive dyskinesia in a patient without known risk factors. Sinha P; Rao R; Sharan P Natl Med J India; 2007; 20(5):271-2. PubMed ID: 18254531 [No Abstract] [Full Text] [Related]
43. Akathisia in adults with severe and profound intellectual disability: a psychometric study of the MEDS and ARMS. Garcia MJ; Matson JL J Intellect Dev Disabil; 2008 Jun; 33(2):171-6. PubMed ID: 18569404 [TBL] [Abstract][Full Text] [Related]
44. Development of tardive dyskinesia in a patient taking amisulpride. Masdrakis VG; Papadimitriou GN; Papageorgiou C; Kouzoupis A; Giailoglou D; Soldatos CR Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):586-7. PubMed ID: 17196725 [No Abstract] [Full Text] [Related]
45. Akathisia: problem of history or concern of today. Iqbal N; Lambert T; Masand P CNS Spectr; 2007 Sep; 12(9 Suppl 14):1-13. PubMed ID: 17805218 [TBL] [Abstract][Full Text] [Related]
46. Intravenous benztropine and propranolol challenges in acute neuroleptic-induced akathisia. Sachdev P; Loneragan C Clin Neuropharmacol; 1993 Aug; 16(4):324-31. PubMed ID: 8104097 [TBL] [Abstract][Full Text] [Related]
47. Pseudoakathisia: a review and two case reports. Stubbs JH; Halstead SM Compr Psychiatry; 2000; 41(1):70-2. PubMed ID: 10646622 [TBL] [Abstract][Full Text] [Related]
50. Informing patients about tardive dyskinesia: A survey of clinicians' attitudes in three countries. Laugharne J; Davies A; Arcelus J; Bouman WP Int J Law Psychiatry; 2004; 27(1):101-8. PubMed ID: 15019771 [No Abstract] [Full Text] [Related]
51. Akathisia: a life-threatening side effect of a common medication. Cheng HM; Park JH; Hernstadt D BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23697447 [TBL] [Abstract][Full Text] [Related]
52. Treatment of Antipsychotic-Related Akathisia Revisited: The Role of Serotonin 2A Receptor Antagonists. Poyurovsky M; Weizman A J Clin Psychopharmacol; 2015 Dec; 35(6):711-4. PubMed ID: 26488676 [TBL] [Abstract][Full Text] [Related]
53. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344 [TBL] [Abstract][Full Text] [Related]
54. Risk of akathisia associated with atypical antipsychotics. Agarkar S; Anthony D; Ferrando S J Neuropsychiatry Clin Neurosci; 2013; 25(1):E46-7. PubMed ID: 23487231 [No Abstract] [Full Text] [Related]
55. [Neuroleptics and akathisia]. Mignot G Therapie; 1987; 42(1):45-50. PubMed ID: 2884749 [No Abstract] [Full Text] [Related]
56. [Three cases of drug-induced akathisia due to antiemetics during cancer palliative care]. Tsuji Y; Miyama S; Uemura Y; Kitanaka N; Yoneda A; Mikayama H; Ohta Y; Teramura S; Sawaragi S; Horikoshi Y; Yamada M; Matsu-ura T; Kitade H; Mori T; Okuno M; Ogura T; Takada H Gan To Kagaku Ryoho; 2006 Feb; 33(2):267-9. PubMed ID: 16484871 [TBL] [Abstract][Full Text] [Related]